Evercore ISI analyst Cory Kasimov downgraded Arcellx (ACLX) to In Line from Outperform with a $115 price target following the announcement that Gilead (GILD) is acquiring the company for $115 per share upfront plus a $5 contingent value right in what the firm calls “the ending most wanted.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACLX: